.NET and Visual Studio Elevation of Privilege Vulnerability
CVE-2023-33135

7.3HIGH

Key Information:

Vendor

Microsoft
Status
.net 6.0
.net 7.0
Microsoft Visual Studio 2022 Version 17.2
Microsoft Visual Studio 2022 Version 17.0
Vendor
CVE Published:
14 June 2023

What is CVE-2023-33135?

The vulnerability in .NET and Visual Studio allows an attacker to elevate privileges within the affected environments, potentially leading to unauthorized access and manipulation of system resources. Attackers can exploit this flaw to bypass application security features, thereby compromising user data and application integrity. It is crucial for users and administrators of affected Microsoft products to implement the necessary updates to mitigate any risks associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

.NET 6.0 Unknown 6.0.0 < 6.0.18

.NET 7.0 Unknown 7.0.0 < 7.0.7

Microsoft Visual Studio 2022 version 17.0 Unknown 17.0.0 < 17.0.22

References

https://msrc.microsoft.com/update-guide/vulnerability/CVE...
vendor-advisory

CVSS V3.1

Score:
7.3
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.